This article has been corrected to clarify that although Thermo Fisher Scientific purchased NovaWave Technologies, it does not operate as a subsidiary of the firm.

NEW YORK (GenomeWeb News) – The CEO of a Thermo Fisher Scientific business is suing the company, alleging Thermo Fisher cheated him and other former shareholders millions of dollars in earn-out payments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Sciencethis week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.